Genetic test outperforms PSA and MRI in spotting deadly prostate cancer early

Genetic test outperforms PSA and MRI in spotting deadly prostate cancer early

Source: News-Medical

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly improved detection of clinically important disease. This approach caught aggressive cancers that standard PSA and MRI screening would have missed.

Targeting men in the top 10% of genetic risk helped detect high-grade prostate cancer that conventional screening would miss, paving the way for more personalized and effective early detection strategies.
Study: Assessment of a Polygenic Risk Score i… [6548 chars]

Read more